Can I read Seladelpar Efficacy in Primary Biliary Cholangitis on EtoBox?

Seladelpar Efficacy in Primary Biliary Cholangitis by 2dtphw6qpc is a document available to read on EtoBox.

What is Seladelpar Efficacy in Primary Biliary Cholangitis about?

The document presents findings from the ASSURE trial, which evaluated the efficacy and safety of Seladelpar, a selective PPARδ agonist, in patients with Primary Biliary Cholangitis (PBC). Results indicate that Seladelpar provides durable biochemical and clinical improvements, including significant reductions in pruritus, with a favorable long-term safety profile. The study supports Seladelpar as a valuable treatment option for patients inadequately responding to standard therapy with Ursodeoxycholic acid (U

Author

2dtphw6qpc

Language

EN